Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Summary In 2018, the US National Institute on Aging and the Alzheimer's Association
proposed a purely biological definition of Alzheimer's disease that relies on biomarkers …
proposed a purely biological definition of Alzheimer's disease that relies on biomarkers …
Tauopathies: new perspectives and challenges
Y Zhang, KM Wu, L Yang, Q Dong, JT Yu - Molecular neurodegeneration, 2022 - Springer
Background Tauopathies are a class of neurodegenerative disorders characterized by
neuronal and/or glial tau-positive inclusions. Main body Clinically, tauopathies can present …
neuronal and/or glial tau-positive inclusions. Main body Clinically, tauopathies can present …
Clinical effects of Lewy body pathology in cognitively impaired individuals
C Quadalti, S Palmqvist, S Hall, M Rossi… - Nature Medicine, 2023 - nature.com
There is poor knowledge about the clinical effects of Lewy body (LB) pathology in patients
with cognitive impairment, especially when coexisting with Alzheimer's disease (AD) …
with cognitive impairment, especially when coexisting with Alzheimer's disease (AD) …
Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration
F Gonzalez-Ortiz, M Turton, PR Kac, D Smirnov… - Brain, 2023 - academic.oup.com
Blood-based biomarkers for amyloid beta and phosphorylated tau show good diagnostic
accuracies and agreements with their corresponding CSF and neuroimaging biomarkers in …
accuracies and agreements with their corresponding CSF and neuroimaging biomarkers in …
New insights into atypical Alzheimer's disease in the era of biomarkers
Most patients with Alzheimer's disease present with amnestic problems; however, a
substantial proportion, over-represented in young-onset cases, have atypical phenotypes …
substantial proportion, over-represented in young-onset cases, have atypical phenotypes …
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
Plasma phosphorylated tau181 (P-tau181) might be increased in Alzheimer's disease (AD),
but its usefulness for differential diagnosis and prognosis is unclear. We studied plasma P …
but its usefulness for differential diagnosis and prognosis is unclear. We studied plasma P …
Frontotemporal lobar degeneration
Frontotemporal lobar degeneration (FTLD) is one of the most common causes of early-onset
dementia and presents with early social–emotional–behavioural and/or language changes …
dementia and presents with early social–emotional–behavioural and/or language changes …
Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson's disease
XB Ding, XX Wang, DH Xia, H Liu, HY Tian, Y Fu… - Nature medicine, 2021 - nature.com
Animal studies implicate meningeal lymphatic dysfunction in the pathogenesis of
neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease (PD) …
neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease (PD) …
Cellular and pathological heterogeneity of primary tauopathies
DC Chung, S Roemer, L Petrucelli… - Molecular …, 2021 - Springer
Microtubule-associated protein tau is abnormally aggregated in neuronal and glial cells in a
range of neurodegenerative diseases that are collectively referred to as tauopathies …
range of neurodegenerative diseases that are collectively referred to as tauopathies …
Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society
Background Consensus criteria for classifying tremor disorders were published by the
International Parkinson and Movement Disorder Society in 1998. Subsequent advances with …
International Parkinson and Movement Disorder Society in 1998. Subsequent advances with …